Palisade Bio Inc (PALI) Live Share Price, Invest From India

Palisade Bio Inc Stock Performance

as on April 3, 2026 at 6:59 am IST

Day's Low
Day's High
$1.81
Day's Price Range
$1.92
$1.90
4.74%
Downside
1.05%
Upside
52 Week's Low
52 Week's High
$0.53
52-Week Price Range
$2.64
$1.90
72.11%
Downside
38.95%
Upside

Palisade Bio Inc share price movements today

Previous Close: $1.88
Open: $1.85
Volume: 3.5M
Day's Low - High: $1.81 - $1.92
52 Week Low - High: $0.53 - $2.64

Palisade Bio Inc Historical Returns

1 Month Return: + 8.62 %
3 Month Return: -24.4 %
1 Year Return: + 164.48 %
3 Year Return: -6.9 %
5 Year Return: 0 %

Palisade Bio Inc Stock Fundamentals & Key Indicators

Check Palisade Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$316.8M

EPS (TTM)

-0.1625

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.39

Industry PE ratio

PEG Ratio

EBITDA

-18.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-24.52%

Palisade Bio Inc Stock Valuation

Track how Palisade Bio Inc P/E has moved over time to understand its valuation trends.

Palisade Bio Inc in the last 5 years

Overview
Trends

Lowest (-18.37x)

June 30, 2021

Industry (0.00x)

April 4, 2026

Today (-0.39x)

April 4, 2026

Highest (11.48x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -0.39x

Palisade Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Palisade Bio Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Palisade Bio Inc	BUY	$316.8M	NA	-0.39	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.3B	124.84%	136.85	8.45%
Beone Medicines Ltd	NA	$35.7B	NA	125.83	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$111.4B	105.93%	28.66	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$80.5B	60.41%	18.38	31.41%

Stock Returns calculator for Palisade Bio Inc Stock including INR - Dollar returns

The Palisade Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Palisade Bio Inc investment value today

Current value as on today

₹2,90,845

Returns

₹1,90,845

(+190.85%)

Returns from Palisade Bio Inc Stock

₹1,67,606 (+167.61%)

Dollar Impact

₹23,240 (+23.24%)

Analyst Recommendation on Palisade Bio Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Palisade Bio Inc. Average target price of $11.29

Palisade Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Palisade Bio Inc.

What analysts predicted

83.17%UPSIDE

Target Price

$11.29

Current Price

$1.9

Analyzed by

8 Analysts

Target

$11.29

Palisade Bio Inc target price $11.29, a slight upside of 83.17% compared to current price of $1.9. According to 8 analysts rating.

Palisade Bio Inc Stock’s Investor Sentiment and Interest

Investment in Palisade Bio Inc Shares on INDmoney has grown by 65.07% over the past 30 days, indicating increased transactional activity.

Time period: March 5, 2026 to April 4, 2026

Change:65.07% versus previous 30 day period

Search interest for Palisade Bio Inc Stock has increased by 242% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 5, 2026 to April 4, 2026

Change:242% versus previous 30 day period

Palisade Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	-
Operating Income	-3	-3	-3	-4	-3	-3	-2	-2	-2	-9
EBITDA	-3	-2	-3	-4	-3	-3	-2	-2	-2	-10
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	-	0	0	0	-	0	0	0	-
Income Before Tax	-3	-2	-3	-4	-3	-3	-2	-2	-2	-8
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-3	-2	-3	-4	-3	-3	-2	-2	-2	-8
Net Profit Margin	0.00%	1188.40%	0.00%	0.00%	0.00%	-83600.00%	0.00%	0.00%	0.00%	0.00%

Palisade Bio Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	0	0	-	0	0	-	-
Gross Profit	0	0	1	0	0	0	0	0	0	0
Operating Income	-20	-13	-8	-8	-9	-41	-15	-13	-14	-18
EBITDA	-19	-15	-4	-8	-9	-24	-14	-12	-14	-18
Interest Expense	1	0	0	0	0	2	0	0	0	0
Depreciation	-	-	-	-	0	0	0	0	0	0
Income Before Tax	-21	-15	-4	-8	-10	-26	-14	-12	-14	-16
Income Tax Expense	0	-2	3	0	0	0	-1	0	-	-
Net Income	-21	-15	-4	-8	-10	-26	-14	-12	-14	-16
Net Profit Margin	-129724.24%	-6025.38%	-1894.23%	-54254.90%	-76346.15%	0.00%	-5704.00%	-4920.00%	0.00%	0.00%

Palisade Bio Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-3	-4	-3	-3	-2	-2	-2	-8
Operating Cash Flow	-2	-3	-3	-3	-2	-2	-1	-3	-3
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	2	3	0	4	0	0	3	131
Change in Cash	-2	-1	0	-3	1	-2	-1	0	128

Palisade Bio Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-15	-4	-8	-10	-26	-14	-12	-14	-16
Operating Cash Flow	-13	-7	-7	-4	-14	-13	-11	-12	-10
Investing Cash Flow	0	4	3	0	0	0	0	-	-
Financing Cash Flow	4	1	6	1	24	15	11	9	134
Change in Cash	-8	0	0	-2	9	1	0	-2	123

Global Institutional Holdings in Palisade Bio Inc

Funds	Holdings
Tower Research Capital LLC	0.05%
Eversept Partners, LP	3.38%
B Group, Inc	2.82%
UBS Group AG	0%
Squarepoint Ops LLC	0.22%

See all

Insights on Palisade Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PALI has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 57.3% return, outperforming this stock by 64.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PALI stock has moved down by -5.5%

About Palisade Bio Inc

Palisade Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and advancing therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company’s lead product candidate, PALI-2108, is being developed as a treatment for patients living with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Fibrostenotic Crohn’s disease (FSCD). The Company is conducting a Phase I human clinical trial of its lead product candidate, PALI-2108, for the treatment of UC. In UC mouse models, the Company has demonstrated the dose-dependent efficacy of PALI-2108. It utilizes dextran sodium sulfate (DSS)-induced UC mouse models and targets engagement in oxazolone-induced colitis. PALI-2108 targets the key phosphodiesterase-4 (PDE4) in colon tissues and prevents it from breaking down cyclic Adenosine Monophosphate (cAMP) molecules which regulate inflammation in the body.

Organisation	Palisade Bio Inc
Headquarters	4600 South Syracuse Street, Denver, CO, United States, 80237
CEO	Mr. J. D. Finley
E-voting on shares	Click here to vote

Key Management of Palisade Bio Inc

Name	Title
Dr. Mitchell Lawrence Jones M.D., Ph.D.	President & Chief Medical Officer
Mr. Ramesh C. Donthamsetty	Head of Corporate Development & Investor Relations
Ms. Sharon Skare Ph.D.	Vice President & Global Head of Clinical Operations
Dr. James Izanec M.D.	VP & Head of Clinical Development
Mr. Daniel J. Larkins	Head of Global Regulatory Affairs
Mr. J. D. Finley	CEO, CFO & Director
Dr. Joerg Heyer Ph.D.	Head of Translational Science & Medicine
Mr. Adarsh Patel M.B.A., M.S.	Head of Chemistry, Manufacturing & Controls
Mr. Ryker Willie	Senior VP of Finance & Corporate Controller

FAQs

What is Palisade Bio Inc share price today?

Palisade Bio Inc share price today is $1.9 as on April 3, 2026 at 1:29 am IST at the close of the market. Palisade Bio Inc share today touched a day high of $1.92 and a low of $1.81.

What is the 52 week high and 52 week low for Palisade Bio Inc share?

Palisade Bio Inc share touched a 52 week high of $2.64 on December 30, 2025 and a 52 week low of $0.53 on September 11, 2025. Palisade Bio Inc stock price today i.e. April 3, 2026 at 1:29 am IST is closed at $1.9,which is 28.03% down from its 52 week high and 258.49% up from its 52 week low.

What is Palisade Bio Inc's market capitalisation today?

Palisade Bio Inc market capitalisation is $0.00T as on April 3, 2026 at 1:29 am IST.

How to invest in Palisade Bio Inc Stock (PALI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Palisade Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Palisade Bio Inc Shares that will get you 0.7895 shares as per Palisade Bio Inc share price of $1.9 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Palisade Bio Inc Stock (PALI) from India?

Indian investors can start investing in Palisade Bio Inc (PALI) shares with as little as ₹92.68 or $1 (as of April 4, 2026 at 9:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.80 in Palisade Bio Inc stock (as per the Rupee-Dollar exchange rate as on April 4, 2026 at 9:39 am IST). Based on Palisade Bio Inc share’s latest price of $1.9 as on April 3, 2026 at 1:29 am IST, you will get 5.2632 shares of Palisade Bio Inc. Learn more about fractional shares .